08329 NEP INTERLONG
- 0.153
- -0.003-1.92%
NEP INTERLONG News
We Think You Can Look Beyond Shenzhen Neptunus Interlong Bio-technique's (HKG:8329) Lackluster Earnings
The market for Shenzhen Neptunus Interlong Bio-technique Company Limited's (HKG:8329) shares didn't move much after it posted weak earnings recently. We think that the softer headline numbers might b
NEP INTERLONG: 2023 Annual Report
Neptune Interlon Announces 2023 Results Profit attributable to shareholders of 24.127 million, a year-on-year decrease of 55.6%
Neptune Interlon (08329) announced its 2023 results, with revenue of about 1,065 billion yuan, up about 7.92% year on year; profit attributable to company owners was 24.127 million yuan, a decrease of 55.6% year on year; profit per share was 1.44 points.
Neptune Interlon (08329) announced 2023 results. Profit attributable to owners of 24.127 million yuan decreased by 55.6% year-on-year
Neptune Interlon (08329) announced its 2023 results, with revenue of about 1,065 billion yuan, an increase of about 7.9 billion yuan over the previous year...
海王英特龍：截至二零二三年十二月三十一日止年度全年業績公佈
海王英特龍：董事會會議日期延期
Neptune Interlon (08329) Fa Profit Alert expects annual profit attributable to shareholders to be reduced by more than 50%
According to the Zhitong Finance App, Neptune Interlon (08329) announced that it is expected that the profit attributable to company owners obtained by the Group for the year ended December 31, 2023 will be reduced by more than 50% compared to the same period in 2022. The main reason for this reduction was due to impairment losses in goodwill formed when the Group acquired Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
NEP INTERLONG: INSIDE INFORMATION ANNOUNCEMENT PROFIT WARNING
Neptune Interlon (08329) and Neptune Easy Pharmaceutical signed a distribution agreement for 2023
According to the Zhitong Finance App, Neptune Interlon (08329) issued an announcement regarding the 2020 Neptune Star Consignment Agreement. Since the 2020 Neptune Star Consignment Agreement will expire on December 31, 2023, on December 28, 2023, the company and Neptune (a related party of the company) signed a 2023 consignment agreement. The Group will supply pharmaceuticals, food, health food and medical equipment to Easy Pharmaceutical Group for consignment sales in China. According to reports, these drugs (mainly including antibiotics, psychosomatic drugs, respiratory drugs, anti-allergy drugs and digestive drugs) and medical equipment are managed by the Group
Neptune Intron announced the first three quarter results, profit attributable to owners of 45.56 million yuan, up 26.81% year on year
Neptune Intron (08329) announced results for the first three quarters of 2023, with revenue of approximately RMB 823 million, up 19.41% year on year; profit attributable to company owners of RMB 45.06 million, up 26.81% year on year; and earnings per share of 2.71 points.
NEP INTERLONG: THIRD QUARTERLY REPORT 2023
Neptune Intron (08329) announced the first three quarter results, profit attributable to owners of 45.56 million yuan, up 26.81% year on year
According to the Zhitong Finance App, Haiwang Intron (08329) announced its results for the first three quarters of 2023, with revenue of approximately RMB 823 million, up 19.41% year on year; profit attributable to company owners of RMB 45.06 million, up 26.81% year on year; earnings per share of 2.71 points.
NEP INTERLONG: ANNOUNCEMENT OF THIRD QUARTERLY RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2023
Aquatic Interlon Announces Interim Results Shareholders' Profit of RMB 298.81 million, up 46.9% year-on-year
Neptune Interlon (08329) announced financial results for the six months ended June 30, 2023, with revenue of 555.5 million yuan (RMB, same below), up 26.6% year on year; shareholder profit of 298.81 million yuan, up 46.9% year on year; and basic profit of 1.78 points per share.
NEP INTERLONG: 2023 INTERIM REPORT
NEP INTERLONG: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
NEP INTERLONG: NOTICE OF BOARD MEETING
NEP INTERLONG: FIRST QUARTERLY REPORT 2023
NEP INTERLONG: ANNOUNCEMENT ON THE FIRST QUARTERLY RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2023
Aquaman Interdragon: 2022 Report
Analysis
Price Target
No Data
